Thirdly, the study could not provide information on certain important specific subtypes for daily clinical haematological practice like ALL with BCR::ABL1 fusion, and AML with RUNX1::RUNX1T1 fusion and CBFB::MYH11 fusion. This evidence concerns the gene RUNX1 and acute myeloid leukemia.